FTC approves Takeda’s Shire acquisition

The U.S. Federal Trade Commission has approved Takeda Pharmaceutical’s acquisition of Shire, according to a press release.

The FTC issued an unconditional clearance of the takeover, which is still subject to other conditions, including other regulatory clearances and shareholder approval, the release said.

Takeda announced in May it would acquire Shire for approximately 46 billion pounds, or 49.01 pounds per Shire share.

The U.S. Federal Trade Commission has approved Takeda Pharmaceutical’s acquisition of Shire, according to a press release.

The FTC issued an unconditional clearance of the takeover, which is still subject to other conditions, including other regulatory clearances and shareholder approval, the release said.

Takeda announced in May it would acquire Shire for approximately 46 billion pounds, or 49.01 pounds per Shire share.